Clinical Presentation, Outcomes, and Treatment of Membranous Nephropathy after Transplantation

Table 2

Clinical presentation of patients with posttransplant MN.

Variables	N = 41
Proteinuria > 0.3 g/g or g/24h, n(%)	31 (75.6)
Proteinuria^1 (g/g or g/24h), mean ± DP	3.2 ± 1.2
Time to onset of proteinuria > 0.3 g/g or g/24h (months), mean ± DP	49.5 ± 49.7 (median = 40)
Serum albumin^1 (g/dL), mean ± DP	3.4 ± 0.6
Serum total cholesterol^1 (mg/dL), mean ± DP	198.8 ± 58.6
Serum triglycerides^1 (mg/dL), mean ± DP	178.5 ± 78.7
Systolic blood pressure^1 (mmHg), mean ± DP	131 ± 7.8
Diastolic blood pressure^1 (mmHg), mean ± DP	82.2 ± 6.5
Graft dysfunction^1, n(%)	14 (34.1)
Serum creatinine^1 (mg/dL), mean ± DP	1.7 ± 0.6
eGFR^1 (mL/min/1.73m^2), mean ± DP	41.9 ± 14.3
eGFR decrease^1 (%), mean ± DP	26.8 ± 16.4
Time between proteinuria and graft biopsy (months), mean ± DP	3.7 ± 2.5
Time between KT and graft biopsy (months), mean ± DP	53.4 ± 51.5 (median = 41)
Histological stages of MN, n(%)
Stage 1	10 (24.4)
Stage 2	25 (60.9)
Stage 3	6 (14.7)

eGFR: estimated glomerular filtration rate; KT: kidney transplant.
¹ At diagnosis.